Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital, Angers
Children's Oncology Group
Essen Biotech
St. Jude Children's Research Hospital
Mayo Clinic
GlaxoSmithKline
St. Jude Children's Research Hospital
Massive Bio, Inc.
Cook Group Incorporated
National Cancer Institute (NCI)
Cellestia Biotech AG
Celgene
Fate Therapeutics
Fate Therapeutics
Leiden University Medical Center
Celgene
Incyte Corporation
Auxilio Mutuo Cancer Center
Incyte Corporation
First Affiliated Hospital of Wenzhou Medical University
National Institutes of Health Clinical Center (CC)
Shenzhen BinDeBio Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mirna Therapeutics, Inc.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center